Literature DB >> 19188581

Direct visualization of remyelination in multiple sclerosis using T2-weighted high-field MRI.

Klaus Schmierer1, Harold G Parkes, Po-Wah So.   

Abstract

Entities:  

Mesh：

Year:  2009        PMID： 19188581      PMCID： PMC2635938          DOI： 10.1212/01.wnl.0000341878.80395.39

Source DB:  PubMed          Journal:  Neurology        ISSN： 0028-3878            Impact factor:   9.910


× No keyword cloud information.
  2 in total

Review 1.  Promoting remyelination in multiple sclerosis by endogenous adult neural stem/precursor cells: defining cellular targets.

Authors:  Chao Zhao; Malgorzata Zawadzka; Aude J A Roulois; Charlotte C Bruce; Robin J M Franklin
Journal:  J Neurol Sci       Date:  2007-06-13       Impact factor: 3.181

Review 2.  Effectors of demyelination and remyelination in the CNS: implications for multiple sclerosis.

Authors:  Moses Rodriguez
Journal:  Brain Pathol       Date:  2007-04       Impact factor: 6.508
  2 in total
  12 in total

1.  Sample-size calculations for short-term proof-of-concept studies of tissue protection and repair in multiple sclerosis lesions via conventional clinical imaging.

Authors:  Daniel S Reich; Richard White; Irene Cm Cortese; Luisa Vuolo; Colin D Shea; Tassie L Collins; John Petkau
Journal:  Mult Scler       Date:  2015-02-06       Impact factor: 6.312

2.  Use of Magnetic Resonance Imaging as Well as Clinical Disease Activity in the Clinical Classification of Multiple Sclerosis and Assessment of Its Course: A Report from an International CMSC Consensus Conference, March 5-7, 2010.

Authors:  Stuart D Cook; Suhayl Dhib-Jalbut; Peter Dowling; Luca Durelli; Corey Ford; Gavin Giovannoni; June Halper; Colleen Harris; Joseph Herbert; David Li; John A Lincoln; Robert Lisak; Fred D Lublin; Claudia F Lucchinetti; Wayne Moore; Robert T Naismith; Carlos Oehninger; Jack Simon; Maria Pia Sormani
Journal:  Int J MS Care       Date:  2012

Review 3.  Imag(in)ing multiple sclerosis: Time to take better pictures.

Authors:  Daniel S Reich
Journal:  J Neuroimmunol       Date:  2016-10-03       Impact factor: 3.478

Review 4.  Remyelinating Pharmacotherapies in Multiple Sclerosis.

Authors:  Riley M Bove; Ari J Green
Journal:  Neurotherapeutics       Date:  2017-10       Impact factor: 7.620

Review 5.  Achievements and obstacles of remyelinating therapies in multiple sclerosis.

Authors:  Martin Stangel; Tanja Kuhlmann; Paul M Matthews; Trevor J Kilpatrick
Journal:  Nat Rev Neurol       Date:  2017-11-17       Impact factor: 42.937

Review 6.  The development of myelin repair agents for treatment of multiple sclerosis: progress and challenges.

Authors:  Robert P Murphy; Keith J Murphy; Mark Pickering
Journal:  Bioengineered       Date:  2012-11-12       Impact factor: 3.269

7.  Multicontrast MR imaging at 7T in multiple sclerosis: highest lesion detection in cortical gray matter with 3D-FLAIR.

Authors:  I D Kilsdonk; W L de Graaf; A Lopez Soriano; J J Zwanenburg; F Visser; J P A Kuijer; J J G Geurts; P J W Pouwels; C H Polman; J A Castelijns; P R Luijten; F Barkhof; M P Wattjes
Journal:  AJNR Am J Neuroradiol       Date:  2012-10-04       Impact factor: 3.825

8.  Postmortem magnetic resonance imaging to guide the pathologic cut: individualized, 3-dimensionally printed cutting boxes for fixed brains.

Authors:  Martina Absinta; Govind Nair; Massimo Filippi; Abhik Ray-Chaudhury; Maria I Reyes-Mantilla; Carlos A Pardo; Daniel S Reich
Journal:  J Neuropathol Exp Neurol       Date:  2014-08       Impact factor: 3.685

Review 9.  Spring cleaning: time to rethink imaging research lines in MS?

Authors:  Martina Absinta; Daniel S Reich; Massimo Filippi
Journal:  J Neurol       Date:  2016-02-17       Impact factor: 4.849

10.  Central nervous system remyelination in culture--a tool for multiple sclerosis research.

Authors:  Hui Zhang; Andrew A Jarjour; Amanda Boyd; Anna Williams
Journal:  Exp Neurol       Date:  2011-04-16       Impact factor: 5.330
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.